LadRx Competitors and Similar CompaniesClear all
ImmunoMet's competitors and similar companies include Fennec Pharma and Urogen Pharma.
 ImmunoMet ImmunoMet is a clinical-stage biotechnological company that specializes in tumor metabolism and immuno-metabolism. |  Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. | ||
Founding Date | Founding Date 2015 | Founding Date 1996 | Founding Date 2004 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Houston, US HQ | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US |
Employees | Employees 814% increase | Employees 433% increase | Employees 194362% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 129.4 m | Valuation ($) 515.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) |
Net income | Net income N/A | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Fennec Pharma
HQ
US
Employees
4↑ 33% increase
Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients.
View company
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View company